Daré Bioscience, Inc. (DARE)
0.4074
-0.04
(-9.86%)
USD |
NASDAQ |
Nov 20, 16:00
0.4092
0.00 (0.00%)
After-Hours: 20:00
Daré Bioscience Price to Book Value : 3.424 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 3.424 |
| November 19, 2026 | 3.798 |
| November 18, 2026 | 3.782 |
| November 17, 2026 | 3.605 |
| November 16, 2026 | 4.909 |
| November 13, 2026 | 5.524 |
| November 12, 2026 | 5.414 |
| November 11, 2026 | 5.833 |
| November 10, 2026 | 5.816 |
| November 09, 2026 | 5.714 |
| November 06, 2026 | 5.370 |
| November 05, 2026 | 5.244 |
| November 04, 2026 | 5.562 |
| November 03, 2026 | 5.462 |
| November 02, 2026 | 5.504 |
| October 30, 2026 | 5.879 |
| October 29, 2026 | 5.727 |
| October 28, 2026 | 5.714 |
| October 27, 2026 | 5.572 |
| October 26, 2026 | 5.410 |
| October 23, 2026 | 5.428 |
| October 22, 2026 | 5.476 |
| October 21, 2026 | 5.782 |
| October 20, 2026 | 5.79 |
| October 19, 2026 | 5.933 |
| Date | Value |
|---|---|
| October 16, 2026 | 6.089 |
| October 15, 2026 | 6.218 |
| October 14, 2026 | 6.126 |
| October 13, 2026 | 6.283 |
| October 12, 2026 | 6.303 |
| October 09, 2026 | 6.499 |
| October 08, 2026 | 6.489 |
| October 07, 2026 | 6.639 |
| October 06, 2026 | 7.001 |
| October 05, 2026 | 7.085 |
| October 02, 2026 | 7.082 |
| October 01, 2026 | 7.151 |
| September 30, 2026 | 7.171 |
| September 29, 2026 | |
| September 28, 2026 | |
| September 25, 2026 | |
| September 24, 2026 | |
| September 23, 2026 | |
| September 22, 2026 | |
| September 21, 2026 | |
| September 18, 2026 | |
| September 17, 2026 | |
| September 16, 2026 | |
| September 15, 2026 | |
| September 14, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Omeros Corp. | -- |
| Aytu BioPharma, Inc. | 0.9159 |
| ANI Pharmaceuticals, Inc. | 2.464 |
| Corcept Therapeutics, Inc. | 8.345 |
| Veru, Inc. | 1.166 |
Price to Book Value Related Metrics
| PS Ratio | 4.427 |
| Price | 0.4074 |
| Earnings Yield | -168.8% |
| Market Cap | 8.014M |